ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,387,000 | -71.3% | 1,311,294 | -50.3% | 0.06% | -74.4% |
| Q2 2022 | $8,307,000 | -49.0% | 2,637,192 | 0.0% | 0.22% | -36.2% |
| Q1 2022 | $16,298,000 | -56.5% | 2,637,192 | 0.0% | 0.34% | -38.4% |
| Q4 2021 | $37,448,000 | +77.5% | 2,637,192 | 0.0% | 0.55% | +72.0% |
| Q3 2021 | $21,098,000 | -75.8% | 2,637,192 | -13.6% | 0.32% | -75.9% |
| Q2 2021 | $87,250,000 | +958.7% | 3,053,919 | +976.5% | 1.32% | +920.9% |
| Q1 2021 | $8,241,000 | – | 283,692 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |